Literature DB >> 22271054

[Intraductal papillary mucinous neoplasia: which findings support observation?].

J Mayerle1, M Kraft, P Menges, P Simon, J Ringel, L I Partecke, C D Heidecke, M M Lerch.   

Abstract

On abdominal CT scans asymptomatic cystic lesions of the pancreas are accidentally detected in 1-2% of patients. Congenital cysts and pancreatic pseudocysts account for two thirds of these lesions. Pancreatic pseudocysts are a frequent complication of acute and chronic pancreatitis. Among resected cystic neoplasms serous cystic adenoma accounts for 30%, mucinous cystic neoplasms for 45% and intraductal papillary mucinous neoplasms for 25%. The diagnosis of a cystic pancreatic lesion is usually made by diagnostic imaging. Symptomatic lesions require definitive therapeutic treatment after appropriate diagnostic work-up. In the diagnosis of asymptomatic cystic lesions several factors are important, among them whether the cyst is connected to the pancreatic duct (as in IPMN and pseudocysts), the size of lesion (for treatment indications) and whether nodules form in the wall of the cyst (a sign of potential malignancy). EUS-guided fine needle aspiration of the cyst fluid adds to the discrimination between benign, premalignant and malignant cystic lesions. Measuring lipase activity, CEA, viscosity and mucin as well as cytology can help in differentiating cystic lesions. An algorithm is discussed for the differential diagnosis and for selection of the appropriate treatment for pancreatic cystic lesions, most of which never require surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22271054     DOI: 10.1007/s00104-011-2183-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

Review 1.  Cystic pancreatic lesions: current evidence for diagnosis and treatment.

Authors:  Josefin Björk Werner; Anna Bartosch-Härlid; Roland Andersson
Journal:  Scand J Gastroenterol       Date:  2011-02-03       Impact factor: 2.423

Review 2.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

3.  Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.

Authors:  Y Sawai; K Yamao; V Bhatia; T Chiba; N Mizuno; A Sawaki; K Takahashi; M Tajika; Y Shimizu; Y Yatabe; A Yanagisawa
Journal:  Endoscopy       Date:  2010-11-30       Impact factor: 10.093

Review 4.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

5.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.

Authors:  Mari Mino-Kenudson; Carlos Fernández-del Castillo; Yoshifumi Baba; Nakul P Valsangkar; Andrew S Liss; Maylee Hsu; Camilo Correa-Gallego; Thun Ingkakul; Rocio Perez Johnston; Brian G Turner; Vasiliki Androutsopoulos; Vikram Deshpande; Deborah McGrath; Dushyant V Sahani; William R Brugge; Shuji Ogino; Martha B Pitman; Andrew L Warshaw; Sarah P Thayer
Journal:  Gut       Date:  2011-04-20       Impact factor: 23.059

6.  Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors:  Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

Authors:  William R Brugge; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; Barbara A Centeno; Tara Szydlo; Susan Regan; Carlos Fernandez del Castillo; Andrew L Warshaw
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

9.  Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Masaharu Ishida; Shinichi Egawa; Takeshi Aoki; Naoaki Sakata; Yukio Mikami; Fuyuhiko Motoi; Tadayoshi Abe; Shoji Fukuyama; Makoto Sunamura; Michiaki Unno; Takuya Moriya; Akira Horii; Toru Furukawa
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

10.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.